Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 15,200 RAPP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 15,200 | n/a |
| May 4, 2026 | Seaport Therapeutics, Inc. (SPTX) | Conversion | 67,031 | n/a |
| Sep 15, 2025 | Rapport Therapeutics, Inc. (RAPP) | Purchase | 28,284 | $692.9K |
| Jun 18, 2025 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 21,850 | n/a |
| Mar 18, 2024 | Karuna Therapeutics, Inc. (KRTX) | Disposition to Issuer | 2,046 | $675.2K |
| Mar 4, 2024 | Karuna Therapeutics, Inc. (KRTX) | Other (see footnotes) | 47,378 | $14.93M |
| Feb 26, 2024 | Karuna Therapeutics, Inc. (KRTX) | Exercise/Conversion | 27,510 | $200.0K |
| Feb 12, 2024 | Karuna Therapeutics, Inc. (KRTX) | Tax Withholding | 804 | $255.0K |
| Jan 4, 2024 | Sage Therapeutics, Inc. (SAGE) | Grant/Award | 3,971 | n/a |
| Apr 5, 2022 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 15,000 | $169.9K |